1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Horizon Europe 2026 Virtual Human Twin Models for AI-Powered Cancer Research and Personalized Oncology is sponsored by European Commission (Horizon Europe Cluster 1 Health and EU Mission on Cancer). The Horizon Europe 2026 Cluster 1 Health work programme funds Virtual Human Twin (VHT) projects that combine AI, multimodal patient data, mechanistic biological models, and high-performance computing to build personalized virtual representations of cancer patients for diagnostic…
Get alerted about grants like this
Get emailed when new opportunities from “European Commission (Horizon Europe Cluster 1 Health and EU Mission on Cancer)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Open to consortia of at least three legal entities established in three different EU Member States or Horizon Europe associated countries. Confirm the full requirements in the official notice before applying.
The current listing shows cancer-focused Virtual Human Twin Research and Innovation Actions typically receive approximately €3,000,000 to €10,000,000 per project (approximately USD 3,200,000 to USD 10,800,000 at 2026 exchange rates) over 3-5 years. The broader Horizon Europe 2026-2027 Work Programme provides approximately €14 billion across calls. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Horizon Europe 2026 Virtual Human Twin Models for AI-Powered Cancer Research and Personalized Oncology are due September 15, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Horizon Europe 2026 Virtual Human Twin Models for AI-Powered Cancer Research and Personalized Oncology is funded by European Commission (Horizon Europe Cluster 1 Health and EU Mission on Cancer). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
The EU's last major Horizon Europe work programme puts €14B on the table through 2027. A strategic breakdown of budgets, deadlines, eligibility, and how US-based teams can compete.
Read articleEUR 307M in Horizon Europe AI calls closed April 15, 2026. US researchers can participate — but the rules are specific. Here is how to navigate them.
Read articleElevance Health Foundation's maternal/infant health RFP closes July 31, 2026, part of a five-year, $150 million commitment. Last cycle it awarded 29 grants totaling $6.5M across the pregnancy continuum. Here is what the funder actually rewards — measurable disparity reduction, a 15% indirect-cost cap, and scalable models — plus how nonprofits in the 10 priority states should frame a competitive proposal.
Read article